• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Disarib

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3603120

Disarib is a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain. More details

Please Inquire
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Disarib, Biochemical
Full Product Name
Disarib
Purity/Purification
>98% (HPLC)
Preparation and Storage
Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack
Molecular Weight
547.855
Target
Bcl-2
Receptor
Bcl-2
Chemical Name
3-((2-(4-chlorobenzyl)-6-(4-bromophenyl)imidazo[2, 1-b][1, 3, 4] -thiadiazol-5-yl)methylidene)-1, 3-dihydro-2H-indol-2-one
Molecular Formula
C26H16BrClN4OS
CAS Number
1998149-15-7

Product Categories/Family for Disarib biochemical

Angiogenesis

Structure of Disarib biochemical

Disarib Biochemical – Cat# MBS3603120

Product References and Citations for Disarib biochemical

1. Iyer D, et al. FEBS J. 2016 Sep; 283 (18):3408-37.
2. Vartak SV, et al. Biochem Pharmacol. 2016 Dec 15; 122:10-22.
3. Vartak SV, et al. Biochem Pharmacol. 2017 May 1; 131:16-28. doi:

Other Notes

Small volumes of Disarib biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Disarib purchase

MBS3603120 is a biochemical targeting Disarib.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000